These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. Watterson D; Kobe B; Young PR J Gen Virol; 2012 Jan; 93(Pt 1):72-82. PubMed ID: 21957126 [TBL] [Abstract][Full Text] [Related]
7. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. Tiwari V; Liu J; Valyi-Nagy T; Shukla D J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749 [TBL] [Abstract][Full Text] [Related]
8. Novel antiviral activity of chemokines. Nakayama T; Shirane J; Hieshima K; Shibano M; Watanabe M; Jin Z; Nagakubo D; Saito T; Shimomura Y; Yoshie O Virology; 2006 Jul; 350(2):484-92. PubMed ID: 16603217 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Marchetti M; Trybala E; Superti F; Johansson M; Bergström T Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565 [TBL] [Abstract][Full Text] [Related]
10. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. Rueda P; Balabanian K; Lagane B; Staropoli I; Chow K; Levoye A; Laguri C; Sadir R; Delaunay T; Izquierdo E; Pablos JL; Lendinez E; Caruz A; Franco D; Baleux F; Lortat-Jacob H; Arenzana-Seisdedos F PLoS One; 2008 Jul; 3(7):e2543. PubMed ID: 18648536 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5). Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808 [TBL] [Abstract][Full Text] [Related]
13. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. Crim RL; Audet SA; Feldman SA; Mostowski HS; Beeler JA J Virol; 2007 Jan; 81(1):261-71. PubMed ID: 17050595 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. Budge PJ; Graham BS J Antimicrob Chemother; 2004 Aug; 54(2):299-302. PubMed ID: 15254023 [TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Techaarpornkul S; Collins PL; Peeples ME Virology; 2002 Mar; 294(2):296-304. PubMed ID: 12009871 [TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties. Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749 [TBL] [Abstract][Full Text] [Related]
18. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G. Budge PJ; Li Y; Beeler JA; Graham BS J Virol; 2004 May; 78(10):5015-22. PubMed ID: 15113882 [TBL] [Abstract][Full Text] [Related]
19. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249 [TBL] [Abstract][Full Text] [Related]
20. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]